Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $8.48 | Prev. Close $8.48 | Circuit Range N/A |
Day Range $8.39 - $8.49 | Year Range $0.26 - $9.70 | Volume 3,336 |
Average Traded $8.47 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $8.48 | $8.48 | +0.00% |
04-Dec-25 | $8.48 | $8.48 | +5.80% |
02-Dec-25 | $8.03 | $8.02 | -7.34% |
26-Nov-25 | $8.88 | $8.65 | +5.55% |
24-Nov-25 | $8.20 | $8.20 | +7.19% |
21-Nov-25 | $7.51 | $7.65 | -1.29% |
20-Nov-25 | $7.75 | $7.75 | -1.08% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?